Summary
- Current Price
- As of today, BIO price is $269.85, down -3.29% on
- Current Price All-Time High
- BIO price is currently -67.59% below its historical high of $832.70 set on
- Market Cap
- BIO current market cap is $7B, up +0.74% over the past 365 days
- PE Ratio
- BIO current PE ratio is 9.67
- Revenue
- BIO current annual revenue is $2.58B, up +0.65% year-over-year
- Next Earnings
- The next earnings release for BIO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Bio-Rad Laboratories, Inc. |
| Ticker | NYSE: BIO |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | bio-rad.com |
| Employees | 7,700 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $269.85 | |
| Price, 1D Change | -3.29% | |
| $7B | ||
| - | ||
| 9.67 | ||
| 1.03 | ||
| $3B | ||
| Revenue, 1Y Change | +0.65% | |
| $27.85 | ||
| EPS, 1Y Change | +142.61% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $27.85 | ||
| EPS Estimate | N/A | $10.27 |
| EPS Est. Change | N/A | -63.13% |
| $2.58B | ||
| Revenue Estimate | N/A | $2.62B |
| Revenue Est. Change | N/A | +1.51% |
| Current Price | $269.85 | |
| Price Target | - | $320.00 |
| Price Tgt. Change | - | +18.58% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $10.06 | -$65.36 | -749.63% | |
| $9.95 | $27.85 | +179.85% | |
| $10.27 | N/A | -63.13% | |
| $11.37 | N/A | -59.19% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.58B | $2.57B | -0.56% | |
| $2.58B | $2.58B | +0.17% | |
| $2.62B | N/A | +1.51% | |
| $2.70B | N/A | +4.71% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $269.85 | |
| $284.24 | ||
| SMA 200 vs Price | +5.33% | |
| $296.44 | ||
| SMA 50 vs Price | +9.85% | |
| 1.03 | ||
| $9.62 | ||
| 38.69 | ||
| 26.20% | ||
| 43.22% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.58B | ||
| $27.85 | ||
| $1.34B | ||
| 52.01% | ||
| $270.50M | ||
| 10.47% | ||
| $759.90M | ||
| 29.42% | ||
| $475.90M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.16 | ||
| 5.62 | ||
| 4.19 | ||
| - | ||
| 5 | ||
| 3.08 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 9.67 | ||
| 2.82 | ||
| 0.98 | ||
| 15.13 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $7.45B | ||
| $1.54B | ||
| $10.58B | ||
| $2.91B | ||
| $3.12B | ||
| $517.00M | ||
| $1.20B | ||
| $1.30M | ||
| $129.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $1.82B | ||
| $1.07B | ||
| $1.24B | ||
| $844.30M | ||
| $205.40M | ||
| $0.00 | ||
| $235.60M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $532.20M | ||
| -$189.70M | ||
| -$283.20M | ||
| $157.60M | ||
| $374.60M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Citigroup | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| Wells Fargo | → | |
| UBS | → | |
| RBC Capital | → | |
| Citigroup | → | |
| Wells Fargo | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with BIO
FAQ
What is the ticker symbol for Bio-Rad Laboratories, Inc.?
The ticker symbol for Bio-Rad Laboratories, Inc. is NYSE:BIO
Does Bio-Rad Laboratories, Inc. pay dividends?
No, Bio-Rad Laboratories, Inc. does not pay dividends
What sector is Bio-Rad Laboratories, Inc. in?
Bio-Rad Laboratories, Inc. is in the Healthcare sector
What industry is Bio-Rad Laboratories, Inc. in?
Bio-Rad Laboratories, Inc. is in the Medical Devices industry
What country is Bio-Rad Laboratories, Inc. based in?
Bio-Rad Laboratories, Inc. is headquartered in United States
When did Bio-Rad Laboratories, Inc. go public?
Bio-Rad Laboratories, Inc. initial public offering (IPO) was on February 27, 1980
Is Bio-Rad Laboratories, Inc. in the S&P 500?
No, Bio-Rad Laboratories, Inc. is not included in the S&P 500 index
Is Bio-Rad Laboratories, Inc. in the NASDAQ 100?
No, Bio-Rad Laboratories, Inc. is not included in the NASDAQ 100 index
Is Bio-Rad Laboratories, Inc. in the Dow Jones?
No, Bio-Rad Laboratories, Inc. is not included in the Dow Jones index
When was Bio-Rad Laboratories, Inc. last earnings report?
Bio-Rad Laboratories, Inc.'s most recent earnings report was on February 12, 2026
When does Bio-Rad Laboratories, Inc. report earnings?
The next expected earnings date for Bio-Rad Laboratories, Inc. is April 30, 2026
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220826000010/0000012208-26-000010-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220826000010/0000012208-26-000010-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio